EDGAR Filing Documents for 0001193125-09-102040

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-09-102040

Filing Date

2009-05-07

Accepted

2009-05-06 21:48:35

Documents

Period of Report

2009-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	572180
2	2009 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS	dex1084.htm	EX-10.84	4475
3	CONSULTING AGREEMENT - SAMUEL R. SAKS, MD	dex1085.htm	EX-10.85	20891
4	CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)	dex311.htm	EX-31.1	10097
5	CERTIFICATION OF ACTING PFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)	dex312.htm	EX-31.2	10130
6	CERTIFICATIONS OF CEO AND ACTING PFO PURSUANT TO 18 U.S.C. SECTION 1350	dex321.htm	EX-32.1	4759
	Complete submission text file	0001193125-09-102040.txt		623915

Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304

Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777

JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)